Aridis Pharmaceuticals, Inc. (ARDS)
Share Price Chart
The chart shows the growth of $10,000 invested in Aridis Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $242 for a total return of roughly -97.58%. All prices are adjusted for splits and dividends.
Compare to other instruments
Aridis Pharmaceuticals, Inc. had a return of -73.38% year-to-date (YTD) and -82.55% in the last 12 months. Over the past 10 years, Aridis Pharmaceuticals, Inc. had an annualized return of -55.74%, while the S&P 500 had an annualized return of 8.86%, indicating that Aridis Pharmaceuticals, Inc. did not perform as well as the benchmark.
|5 years (annualized)||-55.74%||8.86%|
|10 years (annualized)||-55.74%||8.86%|
Monthly Returns Heatmap
Aridis Pharmaceuticals, Inc. doesn't pay dividends
The Drawdowns chart displays portfolio losses from any high point along the way.
The table below shows the maximum drawdowns of the Aridis Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Aridis Pharmaceuticals, Inc. is 97.71%, recorded on Mar 31, 2023. The portfolio has not recovered from it yet.
|-97.71%||Sep 5, 2018||1137||Mar 31, 2023||—||—||—|
|-1.47%||Aug 31, 2018||1||Aug 31, 2018||1||Sep 4, 2018||2|
|-1.15%||Aug 15, 2018||4||Aug 20, 2018||3||Aug 23, 2018||7|
Current Aridis Pharmaceuticals, Inc. volatility is 100.61%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.